18th and 19th November 2018 – BOOSTB4 consortium meeting in Leiden, The Netherlands.


15th October 2018 – UK trial application submitted to the UK Competent Authority, MHRA, for evaluation.


15th October 2018 – Paul-Ehrlich-Institut, the Competent Authority in Germany, confirms receipt of a complete submission of BOOSTB4 trial documents for evaluation.


4th October 2018 – Karolinska Institutet given regulatory approval to begin the BOOSTB4 study by the Swedish Medical Products Agency.


3rd October 2018 – Ethical review board in Stockholm granted Karolinska Institutet permission to conduct the BOOSTB4 trial.


1st October 2018 – BOOSTB4 meeting with MHRA in London to discuss submission to the Competent Authority.


14th August 2018 – Raymond Dalgleish (University of Leicester PI) has secured a grant from Care4BrittleBones, the Dutch OI charity, to bring the OI variant database up to date and transfer the content of the database into the new software.


24th – 25th April 2018 – BOOSTB4 consortium meeting in Lund, Sweden.


20th – 21st September 2017 – BOOSTB4 consortium meeting in Utrecht, The Netherlands.


6th – 7th March 2017 – BOOSTB4 consortium meeting in Cologne, Germany.


11th – 12th October 2016 – BOOSTB4 consortium meeting in London, United Kingdom.


March 2016 – Cecilia Götherström (Project coordinator at Karolinska Institutet) speaks about the BOOSTB4 project on UK television, BBC Two: Incredible Medicine: Dr Weston's Casebook, episode 6.


25th – 26th January 2016 – BOOSTB4 consortium kick-off meeting in Stockholm, Sweden.

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement 681045

© 2019 BOOSTB4 Consortium